Absence of endogenous interleukin‐10 enhances secondary inflammatory process after spinal cord compression injury in mice

Interleukin‐10 (IL‐10) exerts a wide spectrum of regulatory activities in the immune and inflammatory response. The aim of this study was to investigate the role of endogenous IL‐10 on the modulation of the secondary events in mice subjected to spinal cord injury induced by the application of vascular clips (force of 24 g) to the dura via a four‐level T5–T8 laminectomy. IL‐10 wild‐type mice developed severe spinal cord damage characterized by oedema, tissue damage and apoptosis (measured by Annexin‐V, terminal deoxynucleotidyltransferase‐mediated UTP end labeling staining, Bax, Bcl‐2, and Fas‐L expression). Immunohistochemistry demonstrated a marked increase of localization of TNF‐α, IL‐1β and S100β, while western blot analysis shown an increased immunoreactivity of inducible nitric oxide synthase in the spinal cord tissues. The absence of IL‐10 in IL‐10 KO mice resulted in a significant augmentation of all the above described parameters. We have also demonstrated that the genetic absence of IL‐10 worsened the recovery of limb function when compared with IL‐10 wild‐type mice group (evaluated by motor recovery score). Taken together, our results clearly demonstrate that the presence of IL‐10 reduces the development of inflammation and tissue injury events associated with spinal cord trauma.

[1]  S. Lenzen,et al.  Interaction between pro-inflammatory and anti-inflammatory cytokines in insulin-producing cells. , 2008, The Journal of endocrinology.

[2]  G. Schulze-Tanzil,et al.  Interleukin-10 modulates pro-apoptotic effects of TNF-α in human articular chondrocytes in vitro , 2007 .

[3]  S. Rivest,et al.  Neuroprotective role of the innate immune system by microglia , 2007, Neuroscience.

[4]  S. Rivest,et al.  Genes Involved in the Balance between Neuronal Survival and Death during Inflammation , 2007, PloS one.

[5]  G. Schulze-Tanzil,et al.  Interleukin-10 modulates pro-apoptotic effects of TNF-alpha in human articular chondrocytes in vitro. , 2007, Cytokine.

[6]  E. Mazzon,et al.  Poly(ADP-Ribose) Glycohydrolase Activity Mediates Post-Traumatic Inflammatory Reaction after Experimental Spinal Cord Trauma , 2006, Journal of Pharmacology and Experimental Therapeutics.

[7]  H. Keirstead,et al.  Neutralization of the chemokine CXCL10 reduces apoptosis and increases axon sprouting after spinal cord injury , 2006, Journal of neuroscience research.

[8]  E. Mazzon,et al.  Modulation of nitric oxide homeostasis in a mouse model of spinal cord injury. , 2006, Journal of neurosurgery. Spine.

[9]  E. Mazzon,et al.  Role of endogenous ligands for the peroxisome proliferators activated receptors alpha in the secondary damage in experimental spinal cord trauma , 2005, Experimental Neurology.

[10]  S. Cuzzocrea,et al.  Uric acid protects against secondary damage after spinal cord injury. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[11]  C. Hulsebosch,et al.  Exogenous Bcl‐xl fusion protein spares neurons after spinal cord injury , 2005, Journal of neuroscience research.

[12]  N. Patel,et al.  Inhibitors of Poly(ADP-Ribose) Polymerase Modulate Signal Transduction Pathways and Secondary Damage in Experimental Spinal Cord Trauma , 2005, Journal of Pharmacology and Experimental Therapeutics.

[13]  K. Tabuchi,et al.  Immunohistochemical localization of S-100 protein in human cerebral and cerebellar cortices , 1983, Experientia.

[14]  A. O’Garra,et al.  IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage. , 2004, The Journal of clinical investigation.

[15]  S. Cuzzocrea,et al.  Inhibition of the nuclear factor-kappaB activation with pyrrolidine dithiocarbamate attenuating inflammation and oxidative stress after experimental spinal cord trauma in rats. , 2004, Journal of neurosurgery. Spine.

[16]  D. Cocchia Immunocytochemical localization of S-100 protein in the brain of adult rat , 2004, Cell and Tissue Research.

[17]  P. Rouleau,et al.  Proinflammatory Activities of S100: Proteins S100A8, S100A9, and S100A8/A9 Induce Neutrophil Chemotaxis and Adhesion 1 , 2003, The Journal of Immunology.

[18]  D. Prough,et al.  Peroxynitrite generated in the rat spinal cord induces oxidation and nitration of proteins: Reduction by Mn (III) tetrakis (4‐benzoic acid) porphyrin , 2003, Journal of neuroscience research.

[19]  M. Fehlings,et al.  Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: Part 2. Quantitative neuroanatomical assessment and analysis of the relationships between axonal tracts, residual tissue, and locomotor recovery. , 2002, Journal of neurotrauma.

[20]  R. Blumberg,et al.  Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. , 2002, Immunity.

[21]  M. Fehlings,et al.  Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: Part 1. Clip design, behavioral outcomes, and histopathology. , 2002, Journal of neurotrauma.

[22]  F. Aloisi Immune function of microglia , 2001, Glia.

[23]  Christopher L. Wu,et al.  Gene Therapy for the Management of Pain: Part I: Methods and Strategies , 2001, Anesthesiology.

[24]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[25]  A. van Dam,et al.  Interleukin‐10, interleukin‐4, and transforming growth factor‐β differentially regulate lipopolysaccharide‐induced production of pro‐inflammatory cytokines and nitric oxide in co‐cultures of rat astroglial and microglial cells , 2000, Glia.

[26]  R. Simone,et al.  Opposite effects of interferon‐γ and prostaglandin E2 on tumor necrosis factor and interleukin‐10 production in microglia: A regulatory loop controlling microglia pro‐ and anti‐inflammatory activities , 1999, Journal of neuroscience research.

[27]  J. Rothstein,et al.  Motor neuron degeneration is attenuated in bax‐deficient neurons in vitro , 1999, Journal of neuroscience research.

[28]  B. Stokes,et al.  Cytokine mRNA Profiles in Contused Spinal Cord and Axotomized Facial Nucleus Suggest a Beneficial Role for Inflammation and Gliosis , 1998, Experimental Neurology.

[29]  H. Iwata,et al.  Nitric oxide: a possible etiologic factor in spinal cord cavitation. , 1998, Journal of spinal disorders.

[30]  H. Okano,et al.  ICE/CED‐3 Family Executes Oligodendrocyte Apoptosis by Tumor Necrosis Factor , 1997, Journal of neurochemistry.

[31]  G. Salvesen,et al.  FLICE Induced Apoptosis in a Cell-free System , 1997, The Journal of Biological Chemistry.

[32]  D. O’Hanlon,et al.  Accumulation of S100β mRNA and protein in cerebellum during infancy in Down syndrome and control subjects , 1996 .

[33]  D. O’Hanlon,et al.  Accumulation of S100 beta mRNA and protein in cerebellum during infancy in Down syndrome and control subjects. , 1996, Brain research. Molecular brain research.

[34]  N. Sueoka,et al.  Regulation of the rat S100β gene expression: The role of the 2 kb 5′‐upstream sequence in glial specific expression , 1995, Journal of neuroscience research.

[35]  G. Evan,et al.  Induction of apoptosis by the Bcl-2 homologue Bak , 1995, Nature.

[36]  M. Mattson,et al.  S100β protects hippocampal neurons from damage induced by glucose deprivation , 1995, Brain Research.

[37]  M. Schwab,et al.  Methylprednisolone inhibits early inflammatory processes but not ischemic cell death after experimental spinal cord lesion in the rat , 1995, Brain Research.

[38]  D. Basso,et al.  A sensitive and reliable locomotor rating scale for open field testing in rats. , 1995, Journal of neurotrauma.

[39]  M. Mattson,et al.  S100 beta protects hippocampal neurons from damage induced by glucose deprivation. , 1995, Brain research.

[40]  T B Shea,et al.  Technical report. An inexpensive densitometric analysis system using a Macintosh computer and a desktop scanner. , 1994, BioTechniques.

[41]  J. Lederberg,et al.  An early history of gene transfer and therapy. , 1994, Human gene therapy.

[42]  K. Fuxe,et al.  Corticosterone increases FGF-2 (bFGF) immunoreactivity in the substantia nigra of the rat. , 1993, Neuroreport.

[43]  M. Cynader,et al.  Immunohistochemical localization of the S-100 beta protein in postnatal cat visual cortex: spatial and temporal patterns of expression in cortical and subcortical glia. , 1993, Brain research. Developmental brain research.

[44]  P. Baeuerle,et al.  Potential involvement of the transcription factor NF-κB in neurological disorders , 1993 .

[45]  P. Baeuerle,et al.  Potential involvement of the transcription factor NF-kappa B in neurological disorders. , 1993, Molecular aspects of medicine.

[46]  T. Mosmann,et al.  IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. , 1991, Journal of immunology.

[47]  T. Mosmann,et al.  Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. , 1990, Science.

[48]  E. Azmitia,et al.  S-100B but not NGF, EGF, insulin or calmodulin is a CNS serotonergic growth factor , 1990, Brain Research.

[49]  D. Zimmer,et al.  Levels and Distribution of the Calcium‐Modulated Proteins S100 and Calmodulin in Rat C6 Glioma Cells , 1988, Journal of neurochemistry.

[50]  D. Gospodarowicz,et al.  Structural characterization and biological functions of fibroblast growth factor. , 1987, Endocrine reviews.

[51]  K. Mullane,et al.  Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. , 1985, Journal of pharmacological methods.

[52]  INTERNATIONAL SOCIETY FOR NEUROCHEMISTRY , 1976 .

[53]  S. Mughal,et al.  Immunohistochemical localisation of S–100 protein in brain , 1975, Nature.